Jauhiainen S, Ilmonen H, Vuola P, Rasinkangas H, Pulkkinen H, Ker xe4 nen S, et al. ErbB signaling is a potential therapeutic target for vascular lesions with fibrous component. elife. 2023;12: pubmed publisher

Zhou J, Imani S, Shasaltaneh M, Liu S, Lu T, Fu J. PIK3CA hotspot mutations p. H1047R and p. H1047L sensitize breast cancer cells to thymoquinone treatment by regulating the PI3K/Akt1 pathway. Mol Biol Rep. 2021;: pubmed publisher

Ng P, Li J, Jeong K, Shao S, Chen H, Tsang Y, et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018;33:450-462.e10 pubmed publisher